News

Aachen, Germany – September 28, 2026 -- Grünenthal and DKSH Business Unit Healthcare have signed a new commercialisation agreement to bring four pain medicines, Qutenza, Vimovo, Palexia and Zomig, to eight Asia-Pacific markets: Hong Kong, Indonesia, Malaysia, the Philippines, Singapore, Taiwan, Thailand and Vietnam.

DKSH takes over local regulatory filings and distribution across eight markets

Under the agreement, DKSH will seek local marketing authorisations and handle marketing, medical affairs, market access, sales and distribution for the four medicines in each of the eight markets, pending regulatory approval. Grünenthal will retain manufacturing responsibility through its global production network. Each market could gain access to up to four new medicines depending on approval timelines.

Stockholm – September 28, 2026 -- Telefonaktiebolaget LM Ericsson repurchased Class B shares on Nasdaq Stockholm during the week of September 21-25, 2026, lifting its total treasury stock holding to 108,518,663 Class B shares.

Ericsson advances SEK 15 billion buyback program launched in April 2026

The latest repurchases form part of Ericsson's share buyback program of up to SEK 15,000,000,000, announced on April 16, 2026. The program runs from April 23, 2026, through March 31, 2027, at the latest, and is being executed on Ericsson's behalf by Goldman Sachs Bank Europe SE.

Board plans to propose cancellation of repurchased shares at 2027 AGM

Ericsson's Board of Directors intends to propose to the 2027 Annual General Meeting that the repurchased shares be cancelled, with the exception of those retained to fulfil obligations under the company's share-related incentive programs.

Amsterdam – September 28, 2026 -- Arcadis (EURONEXT: ARCAD) has deepened its collaboration with Autodesk to embed artificial intelligence and connected data workflows across design, engineering and project delivery for clients in the built and natural environment sectors.

Automation Cuts Quality Review Time From Five Days to Half a Day

Existing AI and automation initiatives already running across Arcadis operations in North America and Europe have reduced quality reviews from five days to approximately half a day, the company said, demonstrating capacity gains and faster project turnaround.

Dubai – September 27, 2026 -- Aurra Markets was named 'Best Emerging Broker' at Forex Expo Dubai 2026, capping a two-day exhibition at the Dubai World Trade Centre held September 22-23.

Broker Cites Sub-12ms Execution and Zero-Pip Spreads as Award Basis

The company attributes the recognition to its trading infrastructure, which includes sub-12ms execution speeds, raw spreads starting from 0.0 pips, and fully segregated client funds. A company spokesperson said the award reflects the firm's mission to combine Tier-1 liquidity with technical stability for a multi-asset trading ecosystem.

Diamond Sponsor Booth 21 Draws Investors and Media Buyers

Aurra Markets held Diamond Sponsor status at Booth 21, which the company positioned as a focal point for investors, media buyers, and financial professionals evaluating trading technology throughout the expo.

Perth – September 27, 2026 -- PECHOIN, a Chinese skincare brand, is marking its 10th consecutive year of participation at the Congress of the International Federation of Societies of Cosmetic Chemists (IFSCC), presenting new research on Asian skin at what is widely regarded as the cosmetics industry's top scientific forum.

PECHOIN has won seven IFSCC international scientific awards over nine years

The brand became the first IFSCC Gold Member in China and has been recognized three times as the only Gold-level partner in Asia. Over the past decade, PECHOIN has submitted nearly 200 research papers to IFSCC Congresses, with close to 100 accepted. It is also the first Chinese brand to receive the IFSCC Young Scientist Award, doing so three times.

Hong Kong – September 27, 2026 -- Akeso, Inc. (9926.HK) has enrolled the first patient in COMPASSION-37, a global Phase III head-to-head trial testing its bispecific antibody cadonilimab against nivolumab as first-line treatment for HER2-negative advanced gastric and gastroesophageal junction (G/GEJ) adenocarcinoma.

Trial pits cadonilimab plus chemotherapy against nivolumab-based standard of care

The multicenter study compares cadonilimab combined with chemotherapy to chemotherapy with or without nivolumab in previously untreated, unresectable or metastatic G/GEJ patients. It is co-led by Dr. Yelena Y. Janjigian of Memorial Sloan Kettering Cancer Center, Professor Markus Möhler of Johannes Gutenberg University Mainz, and Professors Jiafu Ji and Lin Shen of Peking University Cancer Hospital. Janjigian, Möhler and Shen were investigators on the earlier CheckMate 649 trial, which established nivolumab plus chemotherapy as a global first-line standard.

Seoul, South Korea – September 27, 2026 -- RIMAN, the South Korean beauty and wellness direct-selling company, has expanded to 22 global markets after launching operations in France, Germany and Romania on September 9, followed by Ecuador on September 15.

European footprint grows to seven markets across the region

The three new European launches bring RIMAN's regional presence to seven markets, joining the United Kingdom, Ireland, Spain and Italy. RIMAN's European operations are headquartered in London, where the company runs business training, tools and events for independent Planners. Multilingual customer service and logistics support are based in the United Kingdom and Germany.

Rome – September 27, 2026 -- Yili Group presented a China-based whole-value-chain dairy symbiosis model at the Food and Agriculture Organization's inaugural Global Conference for Actions on One Health in Agrifood Systems, detailing how the company restored 55,000 mu (3,667 hectares) of degraded grassland and helped 5,600,000 herders in Inner Mongolia raise incomes over more than a decade.

Yili restores 3,667 hectares of degraded grassland in Inner Mongolia

In Ar Horqin Banner, Yili Group Vice President XU Ke said the company applied a grass-livestock integration approach, planting deep-rooted alfalfa to stabilize soil and rehabilitate land that had suffered persistent degradation. The restored grassland now supplies forage while supporting broader ecosystem recovery, creating what Yili describes as a self-reinforcing cycle between land, cattle and dairy production.

Seoul – September 27, 2026 -- South Korean premium pet mobility company SEEKOUT is expanding beyond its established Japan export business into North America and Europe, targeting global B2B buyers through overseas trade shows planned for the first half of 2027.

SEEKOUT leverages Japan export track record to enter Western markets

The company built its export foundation by shipping premium pet strollers directly to Japan, a market noted for stringent product quality standards. SEEKOUT is now using that experience as the basis for entering North American and European distribution channels.

Wilmington, Del. – September 27, 2026 -- A new 51-jurisdiction dataset from Cuvo Health shows that only 14 states offer out-of-state physicians a telehealth registration or telemedicine license short of full licensure, exposing a costly compliance gap for digital health startups seeking national scale.